BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005
- 8 July 2005
- journal article
- practice guideline
- Published by Wiley in HIV Medicine
- Vol. 6 (S2) , 62-83
- https://doi.org/10.1111/j.1468-1293.2005.00293.x
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Pharmacokinetic Interactions Between Efavirenz and Rifampicin in HIV-Infected Patients with TuberculosisClinical Pharmacokinetics, 2002
- Use of Rifabutin with Protease Inhibitors for Human Immunodeficiency Virus-Infected Patients with TuberculosisClinical Infectious Diseases, 2000
- Ritonavir Enables Combined Therapy with Rifampin and SaquinavirClinical Infectious Diseases, 1999
- The treatment of tuberculosis in HIV-infected personsAIDS, 1999
- Therapeutic Implications of Drug Interactions in the Treatment of Human Immunodeficiency Virus‐Related TuberculosisClinical Infectious Diseases, 1999
- Paradoxical worsening in tuberculosis during therapy in an HIV-infected patientInfection, 1996
- Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infectionArchives of internal medicine (1960), 1995
- Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patientsAIDS, 1994
- An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1992
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989